DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 197 filers reported holding DENALI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $373,320 | -32.4% | 18,096 | -3.3% | 0.23% | -28.3% |
Q2 2023 | $552,398 | +27.6% | 18,719 | -0.4% | 0.32% | +17.3% |
Q1 2023 | $433,060 | -18.7% | 18,796 | -1.8% | 0.27% | -22.8% |
Q4 2022 | $532,534 | -12.8% | 19,149 | -3.8% | 0.35% | -17.8% |
Q3 2022 | $611,000 | +4.6% | 19,908 | +0.3% | 0.43% | +9.5% |
Q2 2022 | $584,000 | -8.5% | 19,856 | +0.1% | 0.39% | +12.4% |
Q1 2022 | $638,000 | -26.2% | 19,842 | +2.4% | 0.35% | -18.7% |
Q4 2021 | $864,000 | -10.3% | 19,383 | +1.5% | 0.43% | -14.4% |
Q3 2021 | $963,000 | -35.6% | 19,093 | +0.1% | 0.50% | -33.9% |
Q2 2021 | $1,496,000 | +34.2% | 19,074 | -2.3% | 0.76% | +28.2% |
Q1 2021 | $1,115,000 | -31.3% | 19,520 | +0.8% | 0.59% | -38.0% |
Q4 2020 | $1,622,000 | +127.2% | 19,365 | -2.8% | 0.95% | +86.3% |
Q3 2020 | $714,000 | +47.8% | 19,918 | -0.2% | 0.51% | +35.6% |
Q2 2020 | $483,000 | +37.6% | 19,958 | -0.6% | 0.38% | +7.1% |
Q1 2020 | $351,000 | -3.3% | 20,070 | -3.6% | 0.35% | +39.8% |
Q4 2019 | $363,000 | +5.2% | 20,811 | -7.5% | 0.25% | -3.1% |
Q3 2019 | $345,000 | -26.4% | 22,507 | -0.4% | 0.26% | -29.2% |
Q2 2019 | $469,000 | -10.7% | 22,595 | -0.1% | 0.37% | -14.1% |
Q1 2019 | $525,000 | +151.2% | 22,607 | +124.0% | 0.43% | +120.7% |
Q4 2018 | $209,000 | – | 10,092 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |